ORLANDO — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in phlebotomy ...
Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback